Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients.
about
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipientsCalcineurin inhibitor withdrawal or tapering for kidney transplant recipients.Symptomatic lymphoceles after kidney transplantation - multivariate analysis of risk factors and outcome after laparoscopic fenestration.Pilot randomized study of early tacrolimus withdrawal from a regimen with sirolimus plus tacrolimus in kidney transplantation.Intraoperative placing of drains decreases the incidence of lymphocele and deep vein thrombosis after renal transplantation.
P2860
Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Observations on the use of sir ...... k renal transplant recipients.
@en
Observations on the use of sir ...... k renal transplant recipients.
@nl
type
label
Observations on the use of sir ...... k renal transplant recipients.
@en
Observations on the use of sir ...... k renal transplant recipients.
@nl
prefLabel
Observations on the use of sir ...... k renal transplant recipients.
@en
Observations on the use of sir ...... k renal transplant recipients.
@nl
P2093
P1476
Observations on the use of sir ...... k renal transplant recipients.
@en
P2093
P304
P356
10.1016/S0041-1345(03)00238-0
P407
P433
P577
2003-05-01T00:00:00Z